Brooklyn ImmunoTherapeut... Quote - BTX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

9.79

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

52.964M

Previous Close

9.79

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

5,410,000

Dividend Yield

PE Ratio

-0.07

Earnings Per Share (EPS)

-4.01

Revenue

68k

Net Profit

-21.68M

Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immu... Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Television Broadcast Station

Website

eternatx.com

Headquarters

Wilmington, Delaware, USA

Founded

2022

Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial Results

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing...

Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq

NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Reports Inducement Grants

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer

NEW YORK, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts

Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts PR Newswire CAMBRIDGE, Mass., Sept. 15, 2021 CAMBRIDGE, Mass., Sept...

Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET

BROOKLYN, N.Y., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine...

Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience

NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum

BROOKLYN, N.Y., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and...

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021

NEW YORK, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

BTX - Frequently Asked Questions (FAQ)

What is the current Brooklyn ImmunoTherapeut... share price?

The current share price of Brooklyn ImmunoTherapeut... is US$ 9.79

How many Brooklyn ImmunoTherapeut... shares are in issue?

Brooklyn ImmunoTherapeut... has 5,410,000 shares in issue

What is the market cap of Brooklyn ImmunoTherapeut...?

The market capitalisation of Brooklyn ImmunoTherapeut... is USD 52.96M

What is the 1 year trading range for Brooklyn ImmunoTherapeut... share price?

Brooklyn ImmunoTherapeut... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Brooklyn ImmunoTherapeut...?

The price to earnings ratio of Brooklyn ImmunoTherapeut... is -0.07

What is the cash to sales ratio of Brooklyn ImmunoTherapeut...?

The cash to sales ratio of Brooklyn ImmunoTherapeut... is 23.81

What is the reporting currency for Brooklyn ImmunoTherapeut...?

Brooklyn ImmunoTherapeut... reports financial results in USD

What is the latest annual turnover for Brooklyn ImmunoTherapeut...?

The latest annual turnover of Brooklyn ImmunoTherapeut... is USD 68k

What is the latest annual profit for Brooklyn ImmunoTherapeut...?

The latest annual profit of Brooklyn ImmunoTherapeut... is USD -21.68M

What is the registered address of Brooklyn ImmunoTherapeut...?

The registered address for Brooklyn ImmunoTherapeut... is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Brooklyn ImmunoTherapeut... website address?

The website address for Brooklyn ImmunoTherapeut... is eternatx.com

Which industry sector does Brooklyn ImmunoTherapeut... operate in?

Brooklyn ImmunoTherapeut... operates in the TELEVISION BROADCAST STATION sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAPAKairos Pharma Ltd	US$ 2.16 (122.68%)	113.54M
AZTRAzitra Inc	US$ 0.585 (62.50%)	32.82M
ROLRHigh Roller Technologies Inc	US$ 4.26 (26.04%)	111.72k
EONREON Resources Inc	US$ 1.1106 (20.72%)	7.74M
CVUCPI Aerostructures Inc	US$ 5.00 (16.55%)	249.63k
LODEComstock Inc	US$ 0.28205 (-46.78%)	36.33M
OPTTOcean Power Technologies Inc	US$ 0.76325 (-33.63%)	38.1M
HCWCHealthy Choice Wellness Corp	US$ 1.25 (-32.07%)	1.57M
CTMCastellum Inc	US$ 0.720101 (-30.76%)	7.94M
GPUSHyperscale Data Inc	US$ 3.16 (-24.40%)	177.33k
KAPAKairos Pharma Ltd	US$ 2.16 (122.68%)	113.54M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6.445 (-0.23%)	90.34M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.85 (-0.75%)	68.29M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.41 (-4.17%)	55.74M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.29 (3.95%)	50.41M